PUTTING OUR FUTURE IN THE HAND OF OUR CITIZENS
Let’s seize the unique opportunity the Conference on the Future of Europe is offering us to work towards a more democratic, more resilient, more socially just, more innovative, more efficient, fairer and greener Europe.
We call for the creation of a joint European constituency, for democratic standards for elections all across the EU, more rights for the European Parliament, turning the Council into a normal co-legislating second chamber and stronger citizens’ participartion tools.
We want decisions in all policy areas and on all budgetary dossiers to be taken by the ordinary legislative procedure and a deep reform of the Union’s macroeconomic governance to counter structural imbalances and adverse economic shocks.
The European economy in a post-Covid world has to be built on fair socio-economic foundations. In order to ensure that, the EU has to take a more ambitious role in the way to end pay discrimination by ensuring binding measure for equal pay for work of equal value, pay transparency and gendermainstreaming.
The post-covid European economy should be based on tax and social justice, which can be ensured by harmonisation of corporate and environmental tax policies, establishing minimum taxation levels and preventing tax havens.
The EU’s external policy must strengthen solidarity between democracies and work with like-minded countries to push back against authoritarian and hegemonic ambitions. Our trade policy must be conditional on the values of the Union. Europe must continue to offer the Western Balkans a European perspective and pursue its accession talks and enlargement processes with the Western Balkans countries.
We advocate for the ratification of the European Charter of Regional and Minority Languages by all Member States, for an official recognition, promotion and use of regional, minority and lesser-used languages and for the right to self-determination to be protected in the EU.
Subsidies and patents rights must be linked with obligations to disclose the costs of developments for new medicines and to provide medicine in sufficient and resilient manner. EU agencies for the supervision of pharmaceutical producers must be strengthened to coordinate publicly funded research in the public interest and fight monopoly misuse. Europe must also work towards minimum standards to guarantee access to healthcare for everyone living in the EU.
